Oligodendrogliomas Recruiting Phase 2 Trials for Temozolomide (DB00853)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03180502Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaTreatment